Leia M Medlock, MD | |
300 Main St, Laurel, MD 20707-4114 | |
(240) 554-5505 | |
(240) 280-7472 |
Full Name | Leia M Medlock |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 300 Main St, Laurel, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659531077 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MT193601 (Pennsylvania) | Secondary |
207V00000X | Obstetrics & Gynecology | D0074550 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Leia M Medlock, MD 8630m Guilford Rd, Ste 288, Columbia, MD 21046-1404 Ph: (301) 414-2300 | Leia M Medlock, MD 300 Main St, Laurel, MD 20707-4114 Ph: (240) 554-5505 |
News Archive
Endoscopic removal of pre-cancerous cells in patients with confirmed, high-risk Barrett's esophagus is recommended rather than surveillance, according to a new "Medical Position Statement on the Management of Barrett's Esophagus," published by the American Gastroenterological Association (AGA) Institute. The medical position statement was published in Gastroenterology, the official journal of the AGA Institute.
The Medicare will continue to cover Avastin for breast cancer treatment even if U.S. Food and Drug Administration Commissioner Peggy Hamburg decides to withdraw Avastin for such use, according to Don McLeod, a spokesman for the Centers for Medicare and Medicaid. McLeod said, in his statement, "The FDA decision, when it comes, does not affect CMS."
Antares Pharma, Inc., a leader in self-injection drug delivery technology and Uman Pharma, a manufacturer of top-quality injectable pharmaceutical products based in Quebec, Canada, today announced the formation of a strategic alliance covering Antares' VIBEX™ MTX.
This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.
"Health system reform, in combination with economic factors and trends in play, is expected to speed consolidation of health insurers and hospitals, leaving physicians to figure out how they should adapt," American Medical News reports. "The prospect for mergers and acquisitions throughout the industry is high thanks not only to health system reform, but also more access to financing to buy up other companies.
› Verified 9 days ago
Ms. Kalavati J Dave, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8303 Cherry Ln, Laurel, MD 20707 Phone: 301-490-7616 Fax: 301-490-4061 | |
Dr. Rufus Rosser Jr., M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 9811 Mallard Dr, Suite 115, Laurel, MD 20708 Phone: 301-498-2103 Fax: 301-498-2106 |